Inclusion Criteria:  Histologically confirmed HR-positive, HER2-negative advanced breast cancer Treated at Hellenic Cooperative Oncology Group (HeCOG)-affiliated departments of oncology 18 years or older Any menopausal status Treatment with abemaciclib in combination with endocrine therapy Any endocrine therapy At least two months of treatment with abemaciclib